Cardiometabolic diseases (CMD) are a major cause of morbidity and mortality, specifically among African Americans. CMD has origins in youth, and ongoing efforts focus CMD prevention to early adulthood, before clinically overt cardiovascular disease (CVD) or its risk factors develop. We have established that (1) subclini- cal CVD is present in children and young adults and forecasts long-term adverse outcomes; (2) adverse CMD trajectories appear in early adulthood and are associated with mid-life CVD; (3) relative to Caucasians, African Americans exhibit greater cardiac hypertrophy/dysfunction in response to early worsening in CMD risk; (4) tra- ditional metabolic risk factors do not identify African Americans or Caucasians in early adulthood with high life- time CMD risk. These results imply pathophysiologic distinctions in how African Americans respond to CMD and call for more specific markers of metabolic dysregulation early in adulthood for risk stratification. In this re- gard, metabolites and extracellular RNAs (ex-RNAs) are circulating, stable, functional biomolecules that inte- grate metabolic signals across tissues relevant to CMD (hepatic, adipose, muscle, cardiac). We recently ob- served circulating ex-RNAs associated with CMD phenotypes (insulin resistance, hepatic/visceral fat) in older Caucasians in the Framingham Heart Study (FHS). Strikingly, several of these ex-RNAs from FHS were asso- ciated with insulin resistance and adverse metabolite profiles (branched chain amino acids) in children, with in silico analysis suggesting a regulatory role for ex-RNAs in metabolism. Therefore, metabolites and ex-RNAs may sensitively identify global metabolic dysregulation early in CMD. Nevertheless, African Americans and young adults remain underrepresented in studies of metabolomics and ex-RNAs in CMD/CVD, representing a novel locus of investigation for biological insights and risk stratification. Here, we extend our preliminary find- ings in the Coronary Artery Risk Development in Youth (CARDIA) study (1) to identify molecular biomarkers in young adulthood across race that reflect cardiometabolic health transitions through life; (2) to understand how these biomolecules impact long-term clinical disease, leveraging long-term follow-up and CVD/CMD outcomes in CARDIA. In ~2,400 biracial CARDIA participants (45% African American; mean age 32), we hypothesize that circulating metabolites and ex-RNAs dysregulated in early adulthood will identify individuals with poor long-term CMD/CVD risk over >20 years. We will determine metabolite profiles in early adulthood that identify individuals in adverse lifetime CMD trajectories and how they impact long-term CMD risk (e.g., adiposity, met- abolic syndrome; SA1). We will investigate how early adverse metabolite profiles impact future CVD (cardiac hypertrophy, fitness, vascular calcification, clinical outcomes; SA2). Finally, following results in FHS, we will use systems biology to understand implications of ex-RNAs on global metabolic dysfunction (SA3). Completion of this project by our uniquely qualified multidisciplinary team will provide a shared public resource to the broad scientific community for investigation of CMD and CVD in a young, biracial population at high lifetime risk.

Public Health Relevance

Cardiometabolic diseases (CMD)?hypertension, obesity, lipid abnormalities, insulin resistance?afflict a growing number of Americans, especially African Americans. CMD appears early and is related to cardiovascular disease (CVD). Identifying circulating factors early in life that predict ?trajectories? of CMD and development of CVD may lead to better, personalized ways to prevent disease. Here, we study a group of young adults in a longitudinal NIH cohort study to identify molecular markers of CMD (metabolomics and extracellular RNAs) to better understand early determinants of CMD/CVD and its prevention early in adulthood.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL136685-03
Application #
9652741
Study Section
Cancer, Heart, and Sleep Epidemiology B Study Section (CHSB)
Program Officer
Pandey, Mona
Project Start
2017-04-01
Project End
2022-02-28
Budget Start
2019-03-01
Budget End
2020-02-29
Support Year
3
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02114
Bancks, Michael P; Carnethon, Mercedes R; Jacobs Jr, David R et al. (2018) Fasting Glucose Variability in Young Adulthood and Cognitive Function in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Diabetes Care 41:2579-2585
Moody, Jonathan B; Ficaro, Edward P; Murthy, Venkatesh L (2018) Simplified quantification of PET myocardial blood flow: The need for technical standardization. J Nucl Cardiol :
Shah, Ravi V; Rong, Jian; Larson, Martin G et al. (2018) Associations of Circulating Extracellular RNAs With Myocardial Remodeling and Heart Failure. JAMA Cardiol 3:871-876
Shah, Ravi; Ziegler, Olivia; Yeri, Ashish et al. (2018) MicroRNAs Associated With Reverse Left Ventricular Remodeling in Humans Identify Pathways of Heart Failure Progression. Circ Heart Fail 11:e004278
Murthy, Venkatesh L; Nassir, Khurram (2018) Staged testing as a solution to the challenges of testing lower risk patients. J Nucl Cardiol :
Konerman, Matthew C; Greenberg, Joshua C; Kolias, Theodore J et al. (2018) Reduced Myocardial Flow Reserve Is Associated With Diastolic Dysfunction and Decreased Left Atrial Strain in Patients With Normal Ejection Fraction and Epicardial Perfusion. J Card Fail 24:90-100
Lee, Ran; Shah, Ravi V; Murthy, Venkatesh L (2018) Assessment of dyssynchrony by gated myocardial perfusion imaging does not improve patient management. J Nucl Cardiol 25:526-531
Lee, Benjamin C; Moody, Jonathan B; Poitrasson-Rivière, Alexis et al. (2018) Blood pool and tissue phase patient motion effects on 82rubidium PET myocardial blood flow quantification. J Nucl Cardiol :
Thompson, Andrea D; Ficaro, Edward P; Murthy, Venkatesh L et al. (2018) Rescued diagnostic quality by motion correction of dynamic cardiac positron emission tomography (PET) perfusion images. J Nucl Cardiol :
Murthy, Venkatesh L; Eagle, Kim A (2018) ISCHEMIA: A Search for clarity and why we may not find it. Am Heart J 203:82-84

Showing the most recent 10 out of 23 publications